- - Introduction
- - FAQ
Overview
LuciSel 80 mg Capsule
Please fill in the details below, and we’ll get back to you as soon as possible
Similar Products:
| Image | Product | Manufacturer / Marketed By | Price |
|---|---|---|---|
![]() | Retevmo Selpercatinib 40 mg Capsule | Eli Lilly And Company | Ask for Price |
![]() | Selcaxen Selpercatinib 40 mg Capsule | Everest Pharma | Ask for Price |
- - Introduction
- - FAQ
Overview
Description
Discover LuciSel Selpercatinib, a breakthrough kinase inhibitor designed to effectively target and treat specific cancer types. LuciSel is indicated for adult patients with metastatic RET fusion-positive non-small cell lung cancer (NSCLC), providing a vital treatment option for this challenging condition. Additionally, LuciSel Selpercatinib is suitable for both adult and pediatric patients aged 12 years and older who are facing advanced or metastatic RET-mutant medullary thyroid cancer (MTC) requiring systemic therapy. It also caters to those with advanced or metastatic RET fusion-positive thyroid cancer who are radioactive iodine-refractory. Revolutionize your treatment journey with LuciSel Selpercatinib, a targeted solution that harnesses the power of precision medicine to improve outcomes and enhance quality of life.
FAQ
Related Products
Related Posts:
No matching posts found.
Only logged in customers who have purchased this product may leave a review.









Reviews
Clear filtersThere are no reviews yet.